Clinical Trials Directory

Trials / Completed

CompletedNCT04172493

Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Hyperspectral Endoscopy Imaging for Early Detection of Precancerous Lesions in Average Risk Patients: Proof of Principle

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This trial studies whether hyperspectral endoscopy improves visualization of abnormal tissue in average risk patients during standard-of-care colonoscopies. Hyperspectral endoscopy is an emerging technique that has the potential to enable the signals from blood to be resolved from tissue-specific signals. Image-enhanced endoscopy may improve visualization of abnormal colonic tissue when compared to the standard-of-care high-definition white light endoscopy.

Detailed description

PRIMARY OBJECTIVE: I. To assess whether use of hyperspectral endoscopy (HySE) can improve visualization of abnormal colonic tissue. SECONDARY OBJECTIVES: I. To assess whether use of HySE could reduce the rate of missed flat polyps. II. To assess whether use of HySE might in the future reduce the incomplete resection rate (IRR). III. To examine accuracy of practitioners in predicting polyp histology. OUTLINE: Patients undergo standard of care white light endoscopy and hyperspectral endoscopy during routine colonoscopy procedure. After completion of study, patients who experience a colonoscopy-related severe adverse event are followed up until resolution or stabilization of the event.

Conditions

Interventions

TypeNameDescription
PROCEDUREHyperspectral Endoscopy (HySE)Undergo hyperspectral endoscopy
DEVICEWhite Light Endoscopy (WLE)Undergo white light endoscopy

Timeline

Start date
2019-08-26
Primary completion
2020-01-27
Completion
2020-01-27
First posted
2019-11-21
Last updated
2020-05-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04172493. Inclusion in this directory is not an endorsement.